Clinical Trials
4 trialsNCT02301130 2024-04-25
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors
Kyowa Kirin Co., Ltd.
Phase 1 Completed
NCT02281409 2021-04-23
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02444793 2019-02-27
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT01929486 2016-02-17
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
Aichi Medical University
Phase 1 Unknown